298
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

A serum biomarker panel including kallikreins to predict ovarian cancer prognosis and response to chemotherapy

&
Pages 21-23 | Published online: 10 Jan 2014

References

  • Vergote I, van Gorp T, Amant F et al. Timing of debulking surgery in advanced ovarian cancer. Int. J. Gynecol. Cancer18(Suppl. 1), 11–19 (2008).
  • Lusa L, McShane LM, Radmacher MD et al. Appropriateness of some resampling-based inference procedures for assessing performance of prognostic classifiers derived from microarray data. Stat. Med.26(5), 1102–1113 (2007).
  • Paliouras M, Borgono C, Diamandis EP. Human tissue kallikreins: the cancer biomarker family. Cancer Lett.249(1), 61–79 (2007).
  • Zheng Y, Katsaros D, Shan SJ et al. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy. Clin. Cancer Res.13(23), 6984–6992 (2007).
  • Gagnon A, Ye B. Discovery and application of protein biomarkers for ovarian cancer. Curr. Opin. Obstet. Gynecol.20(1), 9–13 (2008).
  • Henry NL, Hayes DF. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. Oncologist11(6), 541–552 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.